The EPO published patent application EP4545046A1 for a transcatheter valve treatment system designed to treat atrioventricular valve leaflet prolapse. Inventor Vitali Verine filed this application, which covers medical device technology for minimally invasive cardiac valve repair. The patent is classified under IPC A61F 2/24 and designates all member states including Germany, France, UK, Italy, Spain, and other European jurisdictions.

This publication represents a standard patent registration notice with no immediate compliance requirements for third parties. Companies developing competing transcatheter valve technologies should review the claims to assess potential overlap with their own intellectual property or to identify opportunities for licensing. No action is required from healthcare providers or device manufacturers unless they are involved in related cardiac device development.